A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT06356571 · RECRUITING

Trial details

NCT number: NCT06356571
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma Refractory

Start date: 2025-03-17
Primary completion: 2027-01-08
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.